Georges Assaf

Title: The Innovations of Georges Assaf

Introduction

Georges Assaf is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of medicine through his innovative work. His research focuses on developing selective inhibitors that can benefit various medical conditions.

Latest Patents

Georges Assaf holds a patent for "Crystalline forms of seletalisib." This patent describes crystalline forms designated as Form B and Form F, which are characterized as selective inhibitors of PI3 kinase enzymes. These inhibitors, particularly targeting the human PBKδ isoform, are beneficial in treating inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive, or ophthalmic conditions. He has 1 patent to his name.

Career Highlights

Georges Assaf is currently employed at UCB Biopharma Sprl, where he continues to advance his research and development efforts. His work is instrumental in the pharmaceutical industry, contributing to the creation of innovative therapies.

Collaborations

Georges collaborates with esteemed colleagues, including Laurent Jacques Willy Delhaye and Vincent Adolphe Carol Cool. Their combined expertise enhances the research and development process at UCB Biopharma Sprl.

Conclusion

Georges Assaf's contributions to the field of medicine through his patent on seletalisib exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements in treatment options for various medical conditions.